Amplia Therapeutics Limited (ATX.AX)
AUD 0.08
(-2.35%)
AUD 0.08
(-2.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 1.56 Million AUD | -30.08% |
| 2023 | 2.26 Million AUD | 8.04% |
| 2022 | 2.1 Million AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | -100.0% |
| 2019 | 10.61 Thousand AUD | 0.0% |
| 2018 | 10.61 Thousand AUD | 3.23% |
| 2017 | 10.28 Thousand AUD | 1.26% |
| 2016 | 10.15 Thousand AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | -100.0% |
| 2013 | 3.06 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 1.56 Million AUD | -31.18% |
| 2024 Q2 | 2.23 Million AUD | 0.0% |
| 2024 Q4 | 1.56 Million AUD | 0.0% |
| 2023 Q4 | 2.26 Million AUD | 0.0% |
| 2023 Q2 | 2.3 Million AUD | 0.0% |
| 2023 FY | 2.26 Million AUD | 8.04% |
| 2022 FY | 2.1 Million AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q4 | 2.1 Million AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 FY | - AUD | -100.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q4 | 10.61 Thousand AUD | 0.0% |
| 2019 FY | 10.61 Thousand AUD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | 10.61 Thousand AUD | 3.23% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 FY | 10.28 Thousand AUD | 1.26% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | 10.15 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q1 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q1 | - AUD | 0.0% |
| 2014 FY | - AUD | -100.0% |
| 2013 FY | 3.06 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -1160.915% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 72.376% |
| Biome Australia Limited | 1.3 Million AUD | -19.606% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -126.437% |
| Imugene Limited | 1.54 Million AUD | -0.956% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | -40.342% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -372.552% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -393.598% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.991% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -77.512% |
| Starpharma Holdings Limited | 3.52 Million AUD | 55.734% |
| Nanollose Limited | 42.53 Thousand AUD | -3572.041% |
| Memphasys Limited | 4.41 Million AUD | 64.612% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -270.104% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 91.048% |
| Dimerix Limited | 149.68 Thousand AUD | -943.351% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | -27.148% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -881.935% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | -5.025% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -21803.492% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 37.395% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -6519.697% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -552.538% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -92.522% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -791.641% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -389.461% |
| Immuron Limited | 173.49 Thousand AUD | -800.142% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |